Advertisement
Advertisement
XAIR
Beyond Air, Inc. Common Stock
5.20
USDSponsored
-0.16
-2.99%
Aug 10, 16:00 UTC -4
Closed
After-Market
5.23
+0.03
+0.58%
XAIR Earnings Reports
Positive Surprise Ratio
XAIR beat 13 of 32 last estimates.
41%
Next Report
Today
Date of Next Report
Aug 10, 2026
Estimate for Q1 27 (Revenue/ EPS)
$1.97M
/-$11.01
Implied change from Q4 26 (Revenue/ EPS)
+3.18%
/-12.62%
Implied change from Q1 26 (Revenue/ EPS)
+11.79%
/-64.02%
Beyond Air, Inc. Common Stock earnings per share and revenue
On Jun 26, 2026, XAIR reported earnings of -12.60 USD per share (EPS) for Q4 26, missing the estimate of -11.56 USD, resulting in a -9.00% surprise. Revenue reached 1.91 million, compared to an expected 2.34 million, with a -18.58% difference. The market reacted with a -6.87% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 6 analysts forecast an EPS of -11.01 USD, with revenue projected to reach 1.97 million USD, implying an decrease of -12.62% EPS, and increase of 3.18% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Bionano Genomics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.69
Actual
-$0.64
Surprise
+8.40%
Biohaven Ltd.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.91
Surprise
-21.67%
Alamar Biosciences, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.33
Actual
-$0.22
Surprise
+33.83%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.55
Actual
-$0.61
Surprise
-9.83%
Enanta Pharmaceuticals, Inc
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.52
Actual
-$0.67
Surprise
-28.80%
Rocket Pharmaceuticals, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.24
Actual
-$0.15
Surprise
-160.80%
Palisade Bio, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.05
Surprise
+6.19%
DiaMedica Therapeutics Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.19
Surprise
+6.86%
Orchestra BioMed Holdings, Inc. Ordinary Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.38
Surprise
+4.95%
Nkarta, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.54
Surprise
-40.81%
FAQ
What were Beyond Air, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Beyond Air, Inc. Common Stock reported EPS of -$12.60, missing estimates by -9%, and revenue of $1.91M, -18.58% below expectations.
How did the market react to Beyond Air, Inc. Common Stock's Q4 2026 earnings?
The stock price moved down -6.87%, changed from $0.37 before the earnings release to $0.35 the day after.
When is Beyond Air, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Beyond Air, Inc. Common Stock's next earnings report?
Based on 6
analysts, Beyond Air, Inc. Common Stock is expected to report EPS of -$11.01 and revenue of $1.97M for Q1 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement